共 494 条
[1]
Reck M(2016)Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer N Engl J Med 375 1823-1833
[2]
Rodriguez-Abreu D(2018)Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer N Engl J Med 378 2078-2092
[3]
Robinson AG(2020)New predictors for immunotherapy responses sharpen our view of the tumour microenvironment Nature 577 474-476
[4]
Hui R(2014)Tertiary lymphoid structures in cancer and beyond Trends Immunol 35 571-580
[5]
Csoszi T(2008)Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures J Clin Oncol 26 4410-4417
[6]
Fulop A(2017)Tertiary lymphoid structures in cancer: drivers of antitumor immunity, immunosuppression, or bystander sentinels in Disease? Front Immunol 8 1830-13497
[7]
Gottfried M(2017)CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer JCI Insight 116 13490-341
[8]
Peled N(2019)Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology Proc Natl Acad Sci U S A 10 1398-844
[9]
Tafreshi A(2019)Tertiary lymphoid organs in cancer immunology: mechanisms and the new strategy for immunotherapy Front Immunol 104 333-1790
[10]
Cuffe S(2018)Role of chemokines in ectopic lymphoid structures formation in autoimmunity and cancer J Leukoc Biol 189 832-267